Susquehanna International Group, LLP Decibel Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$1.86 - $3.54 $60,264 - $114,696	-32,400 Reduced 34.25%	62,200 $127,000
Q3 2022 Nov 14, 2022	SELL	$3.82 - $5.61 $104,668 - $153,714	-27,400 Reduced 22.46%	94,600 $327,000
Q2 2022 Aug 15, 2022	BUY	$1.85 - $4.21 $132,645 - $301,857	71,700 Added 142.54%	122,000 $514,000
Q1 2022 May 16, 2022	BUY	$2.83 - $5.03 $283 - $503	100 Added 0.2%	50,300 $153,000
Q4 2021 Feb 14, 2022	BUY	$4.57 - $8.58 $229,414 - $430,716	50,200 New	50,200 $233,000

Ticker DBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,964,500
Description
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.